Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.70    -0.115 (-2.39%)
Bid:
4.70
Ask:
4.76
Spread: 0.06 (1.277%)
Market Cap: £225.58m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

FOVIO eye-tracking distributor

5 Aug 2014 07:00

RNS Number : 2262O
Seeing Machines Limited
05 August 2014
 



Seeing Machines signs Eye Tracking Inc. to marketFOVIO™ to the eye-tracking research market

Exclusive distributor to deliver next-gen eye-tracking platform

Tuesday 5 August 2014

Seeing Machines (AIM: SEE), a world leader in computer vision related technologies that help machines understand people by tracking and interpreting human faces and eyes, is pleased to announce the signing of EyeTracking Inc. as distributor of Seeing Machines' latest eye-tracking platform, FOVIO. EyeTracking Inc. will have exclusive distribution rights, bundling their industry-leading suite of software and analytic tools with Seeing Machines' world-class gaze-tracking technology platform, to the eye-tracking research market.

Since 2009, EyeTracking Inc. has been a key distributor of Seeing Machines' previous eye-tracking platform, FaceLAB. Seeing Machines' new FOVIO product reinvents eye-tracking capability to deliver higher performance, better accuracy and simpler set up.

EyeTracking Inc., founded in 1999, continues to pioneer the eye-tracking industry with recent patents for novel techniques in analysing 'dynamic areas of interest' and it's software suite, EyeWorks™, eye tracking software to enable simultaneous recording and live view across multiple displays in high-definition.

James Weatherhead, President of EyeTracking Inc. said: "We're delighted to partner with Seeing Machines to continue serving our customers with the latest generation technology platform. It's truly exciting to think about the potential future breakthroughs made possible with the robust eye-tracking performance that FOVIO offers."

Ken Kroeger, CEO of Seeing Machines said: "Given the great relationship that we've developed with ETI, and their pioneering work in developing a robust suite of analytic tools, we're confident that this is the right team to work with to empower the eye-tracking research community. Our entire focus is on our mission to save lives by leveraging operator monitoring technologies. Our approach is to develop strong relationships with the best companies in any market we target. EyeTracking Inc. is the right partner to build sales of our FOVIO product for the specialist research market, allowing us to focus our sales efforts on the large global markets for automotive, mining, transport and aviation applications."

 

 

Enquiries:

Seeing Machines Limited

www.seeingmachines.com

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

James Walker, Finance Director

+61 2 6103 4700

James.Walker@seeingmachines.com

finnCap Ltd, Broker for Seeing Machines

Ed Frisby / Ben Thompson, Corporate Finance

Victoria Bates, Corporate Broking

+44 20 7220 0500

 

Newgate Threadneedle, Investment Communications for Seeing Machines

Robyn McConnachie

Tel: +44 20 7653 9852

Mob: +44 7540 706 191

r.mcconnachie@newgatethreadneedle.com

 

About Seeing Machines

Seeing Machines, (AIM: SEE), is an AIM-listed technology company that specialises in operator monitoring and intervention technologies and services. Its software and engineering services are used in products and applications that range from devices that improve driver safety and save lives to assessing trainees in simulators and simplifying the relationships between people and technology. Seeing Machines technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia, and has offices in Tucson, Arizona and Mountain View, California. The Company counts Caterpillar and EyeTracking Inc. as its partners and BHP Billiton, Freeport McMoran, Teck and Toll Holdings amongst its customers.

 

About EyeTracking Inc.

EyeTracking Inc., founded by Dr. Sandra Marshall and several colleagues from the Cognitive Ergonomics Research Facility at San Diego State University, emerged from two decades of federally funded research in cognition and assessment. Revolutionary methods were developed to accommodate the needs of the US Department of Defense. In February of 1999 EyeTracking Inc. was established to offer the same technology and expertise to the commercial sector. EyeTracking Inc. is a leading provider of eye tracking services, software and expertise. It offers full-service marketing research and usability testing, and bespoke development of eye-tracking solutions. EyeTracking Inc. counts Boeing - Phantom works, DARPA, Lockheed Martin, NASA, MSN, and FAA amongst its customers.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKPLESPLEFF
Date   Source Headline
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.